WELCOME TO MEDSHADOW. WE'VE UPDATED OUR LOOK!

Quick Hits: More Money for Opioid Addiction & More

More Money for Opioid Addiction
More Money for Opioid Addiction

The US Senate has approved the Comprehensive Addiction and Recovery Act (CARA), a bill that would authorize $181 million in new spending to combat the nation’s opioid and heroin abuse crisis. The vote was 92-to-2. The bill now goes before President Obama, who is expected to sign the legislation. Among the important parts of the bill is a provision that would allow certain nurse practitioners and physicians assistants to administer buprenorphine, an opioid addiction medication, to patients. Current federal law only permits doctors to do so and only 100 patients at a time. The White House’s proposed budget for fiscal year 2017 calls for $1.1 billion to combat drug addiction. And just last week, Democrats in Congress tried to add $920 million in new funding to CARA, but were thwarted by Republicans. Posted July 13, 2016. Via USA Today.

Allowing terminally ill patients the right to try experimental medicines not yet approved by the FDA has been adopted by the Republican Party platform committee. Currently, 31 states have so-called “right to try laws” and similar legislation has been introduced in 18 other states. “We commend those states that have passed Right to Try legislation, allowing terminally ill patients the right to try investigational medicines not yet approved by the FDA. We urge Congress to pass similar legislation, giving all Americans with terminal illnesses the right to try,” the amendment to the platform states. Right now, if terminally ill patients can’t get access to an experimental drug through a clinical trial, federal law allows them to petition the FDA to get the drug through “compassionate use.” The agency typically approves most of these requests, though drug makers must also give the green light. Posted July 12, 2016. Via STAT.

 

DISCLAIMER: MedShadow provides information and resources related to medications, their effects, and potential side effects. However, it is important to note that we are not a substitute for professional medical advice, diagnosis, or treatment. The content on our site is intended for educational and informational purposes only. Individuals dealing with medical conditions or symptoms should seek guidance from a licensed healthcare professional, such as a physician or pharmacist, who can provide personalized medical advice tailored to their specific circumstances.

While we strive to ensure the accuracy and reliability of the information presented on MedShadow, we cannot guarantee its completeness or suitability for any particular individual's medical needs. Therefore, we strongly encourage users to consult with qualified healthcare professionals regarding any health-related concerns or decisions. By accessing and using MedShadow, you acknowledge and agree that the information provided on the site is not a substitute for professional medical advice and that you should always consult with a qualified healthcare provider for any medical concerns.

Was This Article Helpful?

Show Comments (0)
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x